Pfizer Inc (PFE)
Pfizer Inc. - TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Pfizer Inc. - TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Lands’ End Announces Fourth Quarter and Full Year Fiscal 2025 Results
Caleres Reports Fourth Quarter & Fiscal 2025 Results
Lindsay Corporation Announces Second Quarter Fiscal 2026 Earnings Conference Call and Webcast
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer
Movado Group, Inc. Announces Fourth Quarter and Fiscal Year 2026 Results
Titan Machinery Inc. Announces Results for Fiscal Fourth Quarter and Full Year Ended January 31, 2026
Register of shareholders, changes and capital status – private allocation of warrants
Accenture Reports Second-Quarter Fiscal 2026 Results